{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:48:01Z","timestamp":1782953281508,"version":"3.54.5"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI21C0977"],"award-info":[{"award-number":["HI21C0977"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003663","name":"Small and Medium Business Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.yexmp.2025.105004","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T01:05:35Z","timestamp":1760576735000},"page":"105004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mechanism and importance of ferroptosis in clear cell renal cell carcinoma treatment"],"prefix":"10.1016","volume":"144","author":[{"given":"Manvi Agarwal","family":"Neeraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songmi","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JeeHoon","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JunJeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yexmp.2025.105004_bb0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40265-022-01683-6","article-title":"First-line immune checkpoint inhibitor combinations in metastatic renal cell carcinoma: where are we going, where have we been?","volume":"82","author":"Adashek","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.yexmp.2025.105004_bb0010","first-page":"12","article-title":"Molecular mechanisms of mitochondria-mediated ferroptosis: a potential target for antimalarial interventions. Front cell","author":"Adegboro","year":"2024","journal-title":"Dev. Biol."},{"key":"10.1016\/j.yexmp.2025.105004_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.810262","article-title":"Risk factors for the comorbidity of hypertension and renal cell carcinoma in the cardio-oncologic era and treatment for tumor-induced hypertension","volume":"9","author":"Ba","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.yexmp.2025.105004_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.eururo.2024.10.019","article-title":"First and second-line treatments in metastatic renal cell carcinoma","volume":"87","author":"Barragan-Carrillo","year":"2025","journal-title":"Eur. Urol."},{"issue":"10","key":"10.1016\/j.yexmp.2025.105004_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17101613","article-title":"Molecular mechanisms of drug resistance in clear cell renal cell carcinoma","volume":"17","author":"Bianchi","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1476-5381.2011.01480.x","article-title":"System xc- cystine\/glutamate antiporter: an update on molecular pharmacology and roles within the CNS","volume":"165","author":"Bridges","year":"2012","journal-title":"Brit. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11418-015-0931-7","article-title":"Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells","volume":"70","author":"Busaranon","year":"2016","journal-title":"J. Nat. Med. Tokyo"},{"issue":"4","key":"10.1016\/j.yexmp.2025.105004_bb0045","first-page":"1143","article-title":"Iron metabolism and its contribution to cancer (review)","volume":"54","author":"Chen","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.yexmp.2025.105004_bb0050","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"issue":"13","key":"10.1016\/j.yexmp.2025.105004_bb0055","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.7150\/ijbs.85692","article-title":"FGF2 alleviates microvascular ischemia-reperfusion injury by KLF2-mediated Ferroptosis inhibition and antioxidant responses","volume":"19","author":"Chen","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.yexmp.2025.105004_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41388-024-03219-6","article-title":"Breathing new insights into the role of mutant p53 in lung cancer","volume":"44","author":"Chen","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.yexmp.2025.105004_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111421","article-title":"TRIB3 knockdown increases the sensitivity of clear cell renal cell carcinoma to sunitinib by inducing ferroptosis","volume":"124","author":"Chen","year":"2024","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.yexmp.2025.105004_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70071","article-title":"Moscatilin induces Ferroptosis in clear cell renal cell carcinoma via the JAK-STAT signaling pathway","volume":"105","author":"Chen","year":"2025","journal-title":"Chem. Biol. Drug Des."},{"issue":"6","key":"10.1016\/j.yexmp.2025.105004_bb0075","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ndt\/gfae036","article-title":"Global epidemiology of kidney cancer","volume":"39","author":"Cirillo","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-024-03235-0","article-title":"Ferroptosis and the tumor microenvironment","volume":"43","author":"Cui","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.yexmp.2025.105004_bb0085","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2015.06.042","article-title":"The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks","volume":"70","author":"Cumberbatch","year":"2016","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0090","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"7784","key":"10.1016\/j.yexmp.2025.105004_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.yexmp.2025.105004_bb0100","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.tcb.2023.04.005","article-title":"Ferroptosis: mechanisms and implications for cancer development and therapy response","volume":"33","author":"dos Santos","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0105","article-title":"Recent progress in ferroptosis: inducers and inhibitors","volume":"8","author":"Du","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexmp.2025.105004_bb0110","first-page":"36","article-title":"Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma","author":"Du","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.yexmp.2025.105004_bb0115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.molcel.2012.05.043","article-title":"Glutaminolysis activates rag-mTORC1 signaling","volume":"47","author":"Dur\u00e1n","year":"2012","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0120","article-title":"Frontier knowledge and future directions of programmed cell death in clear cell renal cell carcinoma","volume":"10","author":"Fei","year":"2024","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006203","article-title":"Unsolved mysteries: how does lipid peroxidation cause ferroptosis?","volume":"16","author":"Feng","year":"2018","journal-title":"PLoS Biol."},{"issue":"10","key":"10.1016\/j.yexmp.2025.105004_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.02.049","article-title":"Transferrin receptor is a specific Ferroptosis marker","volume":"30","author":"Feng","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0135","article-title":"MDH2 regulates the sensitivity of clear cell renal cell carcinoma to ferroptosis through its interaction with FSP1","volume":"10","author":"Feng","year":"2024","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.yexmp.2025.105004_bb0140","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114351","article-title":"YAP\/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis","volume":"13","author":"Gao","year":"2021","journal-title":"Embo Mol. Med."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0145","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12672-024-01573-1","article-title":"Current advances on the role of ferroptosis in tumor immune evasion","volume":"15","author":"Gao","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.yexmp.2025.105004_bb0150","first-page":"15","article-title":"Broadening horizons: the multifaceted role of ferroptosis in breast cancer","author":"Ge","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.yexmp.2025.105004_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063404","article-title":"Renal cell Cancer and obesity","volume":"23","author":"Gluba-Brzozka","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.yexmp.2025.105004_bb0160","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/pro.5560031027","article-title":"Malate-dehydrogenase - a model for structure, evolution, and catalysis","volume":"3","author":"Goward","year":"1994","journal-title":"Protein Sci."},{"issue":"36","key":"10.1016\/j.yexmp.2025.105004_bb0165","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.79.0147","article-title":"Prognostication in kidney cancer: recent advances and future directions","volume":"36","author":"Graham","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"42","key":"10.1016\/j.yexmp.2025.105004_bb0170","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1038\/s41388-022-02460-1","article-title":"ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma","volume":"41","author":"Green","year":"2022","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.yexmp.2025.105004_bb0175","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.21037\/tcr-21-2157","article-title":"Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma","volume":"11","author":"Guo","year":"2022","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.1014","article-title":"Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma","volume":"44","author":"Guo","year":"2011","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccell.2015.12.004","article-title":"An integrated metabolic atlas of clear cell renal cell carcinoma","volume":"29","author":"Hakimi","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexmp.2025.105004_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3846217","article-title":"HO-1 contributes to Luteolin-triggered Ferroptosis in clear cell renal cell carcinoma via increasing the labile iron pool and promoting lipid peroxidation","volume":"2022","author":"Han","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.yexmp.2025.105004_bb0195","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/bjc.2014.450","article-title":"Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma","volume":"111","author":"Hofbauer","year":"2014","journal-title":"Brit. J. Cancer"},{"issue":"3","key":"10.1016\/j.yexmp.2025.105004_bb0200","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7150\/ijbs.29737","article-title":"TRIB3 promotes the proliferation and invasion of renal cell carcinoma cells via activating MAPK signaling pathway","volume":"15","author":"Hong","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexmp.2025.105004_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108612","article-title":"Luteolin, a flavonoid, as an anticancer agent: a review","volume":"112","author":"Imran","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"7545","key":"10.1016\/j.yexmp.2025.105004_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.yexmp.2025.105004_bb0215","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41585-018-0023-z","article-title":"Epigenetics in renal cell cancer: mechanisms and clinical applications","volume":"15","author":"Joosten","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"18","key":"10.1016\/j.yexmp.2025.105004_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189795","article-title":"Loss of Von Hippel-Lindau (VHL) tumor suppressor gene function: VHL-HIF pathway and advances in treatments for metastatic renal cell carcinoma (RCC)","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40170-022-00290-z","article-title":"ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma","volume":"10","author":"Klasson","year":"2022","journal-title":"Cancer Metab."},{"issue":"3","key":"10.1016\/j.yexmp.2025.105004_bb0230","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1371\/journal.pbio.0000083","article-title":"Inhibition of HIF2\u03b1 is sufficient to suppress pVHL-defective tumor growth","volume":"1","author":"Kondo","year":"2003","journal-title":"PLoS Biol."},{"key":"10.1016\/j.yexmp.2025.105004_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5571638","article-title":"Loss of function of von Hippel-Lindau trigger Lipocalin 2-dependent inflammatory responses in cultured and primary renal tubular cells","volume":"2021","author":"Kuo","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.yexmp.2025.105004_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7736638","article-title":"The von Hippel-Lindau tumor suppressor gene mutations modulate Lipocalin-2 expression in Ferroptotic-inflammatory pathways","volume":"2023","author":"Kuo","year":"2023","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-019-0939-2","article-title":"Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy","volume":"19","author":"Lai","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.yexmp.2025.105004_bb0250","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11010-024-05009-w","article-title":"Important molecular mechanisms in ferroptosis","volume":"480","author":"Lai","year":"2024","journal-title":"Mol. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.yexmp.2025.105004_bb0255","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and immunotherapy promote tumoral lipid oxidation and Ferroptosis via synergistic repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0260","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/hep.31594","article-title":"Deficiency of histone methyltransferase SET domain-containing 2 in liver leads to abnormal lipid metabolism and HCC","volume":"73","author":"Li","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.yexmp.2025.105004_bb0265","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2024.14576","article-title":"Interference with ENO2 promotes ferroptosis and inhibits glycolysis in clear cell renal cell carcinoma by regulating Hippo-YAP1 signaling","volume":"28","author":"Li","year":"2024","journal-title":"Oncol. Lett."},{"issue":"7\u20138","key":"10.1016\/j.yexmp.2025.105004_bb0270","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s10495-024-01953-6","article-title":"Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells","volume":"29","author":"Li","year":"2024","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0275","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02213-6","article-title":"Tailoring traditional Chinese medicine in cancer therapy","volume":"24","author":"Li","year":"2025","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.yexmp.2025.105004_bb0280","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41585-024-00876-w","article-title":"Von Hippel-Lindau protein signalling in clear cell renal cell carcinoma","volume":"21","author":"Liao","year":"2024","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.yexmp.2025.105004_bb0285","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/cas.13961","article-title":"Kruppel-like factor 2 inhibits hepatocarcinogenesis through negative regulation of the hedgehog pathway","volume":"110","author":"Lin","year":"2019","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.yexmp.2025.105004_bb0290","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.tem.2024.09.003","article-title":"Targeting ACSLs to modulate ferroptosis and cancer immunity","volume":"36","author":"Lin","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0295","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","article-title":"The genetic basis of kidney cancer: a metabolic disease","volume":"7","author":"Linehan","year":"2010","journal-title":"Nat. Rev. Urol."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0300","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","article-title":"p53 in ferroptosis regulation: the new weapon for the old guardian","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexmp.2025.105004_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103342","article-title":"Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1\/Nrf2\/HO-1 pathway","volume":"76","author":"Liu","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.yexmp.2025.105004_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.09.014","article-title":"KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma","volume":"522","author":"Lu","year":"2021","journal-title":"Cancer Lett."},{"issue":"15","key":"10.1016\/j.yexmp.2025.105004_bb0315","article-title":"ENO2 promotes colorectal cancer metastasis by interacting with the LncRNA CYTOR and activating YAP1-induced EMT","volume":"11","author":"Lv","year":"2022","journal-title":"Cells-Basel"},{"key":"10.1016\/j.yexmp.2025.105004_bb0320","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/nyas.13008","article-title":"Iron and cancer: recent insights","volume":"1368","author":"Manz","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.yexmp.2025.105004_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2024.105977","article-title":"TRIB3 promotes the growth of oral squamous cell carcinoma by regulating JNK\/JUN-mediated aerobic glycolysis","volume":"164","author":"Meng","year":"2024","journal-title":"Arch. Oral Biol."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0330","article-title":"Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma. Bmc","volume":"21","author":"Mou","year":"2021","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0335","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","article-title":"A genomic and functional inventory of deubiquitinating enzymes","volume":"123","author":"Nijman","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2025.105004_bb0340","first-page":"15","article-title":"Revealing the characteristics of SETD2-mutated clear cell renal cell carcinoma through tumor heterogeneity analysis","author":"Peng","year":"2024","journal-title":"Front. Genet."},{"issue":"11","key":"10.1016\/j.yexmp.2025.105004_bb0345","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1021\/acs.jmedchem.5c00280","article-title":"Discovery of THB Derivates as Ferroptosis inhibitors for the treatment of acute kidney injury by targeting VDAC","volume":"68","author":"Peng","year":"2025","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.yexmp.2025.105004_bb0350","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.celrep.2014.05.026","article-title":"SETD2-dependent histone H3K36 Trimethylation is required for homologous recombination repair and genome stability","volume":"7","author":"Pfister","year":"2014","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0355","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1194\/jlr.M024562","article-title":"The N-terminal region of acyl-CoA synthetase 3 is essential for both the localization on lipid droplets and the function in fatty acid uptake","volume":"53","author":"Poppelreuther","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.yexmp.2025.105004_bb0360","first-page":"11","article-title":"The uniqueness of clear cell renal cell carcinoma: summary of the process and abnormality of glucose metabolism and lipid metabolism in ccRCC","author":"Qi","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexmp.2025.105004_bb0365","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ebiom.2019.01.021","article-title":"Krupsilonppel-like factors (KLFs) in renal physiology and disease","volume":"40","author":"Rane","year":"2019","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.yexmp.2025.105004_bb0370","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15592294.2017.1281502","article-title":"A drive in SUVs: from development to disease","volume":"12","author":"Rao","year":"2017","journal-title":"Epigenetics-Us"},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0375","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43378-w","article-title":"SETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer","volume":"14","author":"Rao","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.yexmp.2025.105004_bb0380","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41416-019-0655-7","article-title":"The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma","volume":"122","author":"Rehwald","year":"2020","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.yexmp.2025.105004_bb0385","first-page":"6","article-title":"Lipidomic signatures and associated transcriptomic profiles of clear cell renal cell carcinoma","author":"Saito","year":"2016","journal-title":"Sci. Rep. UK"},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0390","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nsmb1222","article-title":"Iron-regulatory proteins limit hypoxia-inducible factor-2\u03b1 expression in iron deficiency","volume":"14","author":"Sanchez","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.yexmp.2025.105004_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106222","article-title":"Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC)","volume":"81","author":"Shen","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexmp.2025.105004_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216645","article-title":"Pioneering the future of cancer therapy: deciphering the p53-ferroptosis nexus for precision medicine","volume":"585","author":"Shin","year":"2024","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.yexmp.2025.105004_bb0405","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0410","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1158\/1541-7786.MCR-14-0536","article-title":"mTOR\/MYC Axis regulates O-GlcNAc transferase expression and O-GlcNAcylation in breast cancer","volume":"13","author":"Sodi","year":"2015","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0415","doi-asserted-by":"crossref","DOI":"10.1177\/15593258211001251","article-title":"Moscatilin suppresses the breast cancer both in vitro and in vivo by inhibiting HDAC3","volume":"19","author":"Su","year":"2021","journal-title":"Dose-Response"},{"issue":"6","key":"10.1016\/j.yexmp.2025.105004_bb0420","article-title":"Salinomycin inhibits SREBP1 to sensitize ferroptosis and ameliorate sorafenib resistance in clear cell renal cell carcinoma. Bba-Mol","volume":"1872","author":"Su","year":"2025","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0425","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1464-410X.2007.06765.x","article-title":"Differential expression of facilitative glucose transporters in normal and tumour kidney tissues","volume":"99","author":"Suganuma","year":"2007","journal-title":"BJU Int."},{"issue":"8","key":"10.1016\/j.yexmp.2025.105004_bb0430","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1158\/2159-8290.CD-20-1453","article-title":"Obesity-dependent Adipokine Chemerin suppresses fatty acid oxidation to confer Ferroptosis resistance","volume":"11","author":"Tan","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0435","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41585-022-00654-6","article-title":"Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets","volume":"20","author":"Tan","year":"2023","journal-title":"Nat. Rev. Urol."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0440","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.yexmp.2025.105004_bb0445","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.celrep.2017.12.077","article-title":"p53 suppresses metabolic stress-induced Ferroptosis in cancer cells","volume":"22","author":"Tarangelo","year":"2018","journal-title":"Cell Rep."},{"issue":"7823","key":"10.1016\/j.yexmp.2025.105004_bb0450","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.yexmp.2025.105004_bb0455","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","article-title":"ATF3 promotes erastin-induced ferroptosis by suppressing system Xc","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.yexmp.2025.105004_bb0460","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.apsb.2020.09.015","article-title":"SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.yexmp.2025.105004_bb0465","article-title":"ISCA2 deficiency leads to heme synthesis defects and impaired erythroid differentiation in K562 cells by indirect ROS-mediated IRP1 activation. Bba-Mol","volume":"1869","author":"Wang","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.yexmp.2025.105004_bb0470","article-title":"Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma","volume":"809","author":"Wang","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.yexmp.2025.105004_bb0475","first-page":"51","article-title":"ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury","author":"Wang","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.yexmp.2025.105004_bb0480","first-page":"32","article-title":"A glutathione-responsive ferroptotic inducer with elevated labile iron pool and self-supplied peroxide for chemodynamic therapy","author":"Wei","year":"2025","journal-title":"Mater. Today Bio."},{"issue":"7","key":"10.1016\/j.yexmp.2025.105004_bb0485","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrneph.2017.59","article-title":"Metabolic reprogramming in clear cell renal cell carcinoma","volume":"13","author":"Wettersten","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.yexmp.2025.105004_bb0490","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0495","article-title":"GABPA inhibits tumorigenesis in clear cell renal cell carcinoma by regulating ferroptosis through ACSL4","volume":"14","author":"Wu","year":"2024","journal-title":"Sci. Rep. UK"},{"key":"10.1016\/j.yexmp.2025.105004_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122498","article-title":"Suv39h1 contributes to activation of hepatic stellate cells in non-alcoholic fatty liver disease by enabling anaerobic glycolysis","volume":"341","author":"Wu","year":"2024","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.yexmp.2025.105004_bb0505","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","article-title":"The tumor suppressor p53 limits Ferroptosis by blocking DPP4 activity","volume":"20","author":"Xie","year":"2017","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.yexmp.2025.105004_bb0510","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.21037\/tcr-21-227","article-title":"Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the ADAMTS18 gene","volume":"10","author":"Xu","year":"2021","journal-title":"Transl. Cancer Res."},{"issue":"8","key":"10.1016\/j.yexmp.2025.105004_bb0515","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06057-8","article-title":"Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC","volume":"14","author":"Xue","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1\u20132","key":"10.1016\/j.yexmp.2025.105004_bb0520","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of Ferroptotic Cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"34","key":"10.1016\/j.yexmp.2025.105004_bb0525","doi-asserted-by":"crossref","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"23","key":"10.1016\/j.yexmp.2025.105004_bb0530","article-title":"ACSL3 and ACSL4, distinct roles in Ferroptosis and cancers","volume":"14","author":"Yang","year":"2022","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.yexmp.2025.105004_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108148","article-title":"OGT\/HIF-2\u03b1 axis promotes the progression of clear cell renal cell carcinoma and regulates its sensitivity to ferroptosis","volume":"26","author":"Yang","year":"2023","journal-title":"Iscience"},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0540","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-023-01384-y","article-title":"The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma","volume":"18","author":"Yang","year":"2023","journal-title":"Diagn. Pathol."},{"issue":"49","key":"10.1016\/j.yexmp.2025.105004_bb0545","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.yexmp.2025.105004_bb0550","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41388-020-01622-3","article-title":"Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0555","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5582\/bst.2021.01318","article-title":"The positive role of traditional Chinese medicine as an adjunctive therapy for cancer","volume":"15","author":"Zhang","year":"2021","journal-title":"Biosci. Trends"},{"issue":"9","key":"10.1016\/j.yexmp.2025.105004_bb0560","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.tcb.2022.02.009","article-title":"Transsulfuration, minor player or crucial for cysteine homeostasis in cancer","volume":"32","author":"Zhang","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.yexmp.2025.105004_bb0565","article-title":"MITD1 deficiency suppresses clear cell renal cell carcinoma growth and migration by inducing Ferroptosis through the TAZ\/SLC7A11 pathway","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0570","article-title":"SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma. Bmc","volume":"23","author":"Zhang","year":"2023","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.yexmp.2025.105004_bb0575","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2021.13028","article-title":"Propofol induces the ferroptosis of colorectal cancer cells by downregulating STAT3 expression","volume":"22","author":"Zhao","year":"2021","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105004_bb0580","article-title":"Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer","volume":"5","author":"Zheng","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.yexmp.2025.105004_bb0585","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3892\/ol.2023.13676","article-title":"HIF-1alpha inhibits ferroptosis and promotes malignant progression in non-small cell lung cancer by activating the hippo-YAP signalling pathway","volume":"25","author":"Zheng","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexmp.2025.105004_bb0590","first-page":"32","article-title":"Engineering charge density in s-block potassium single-atom nanozyme for amplified ferroptosis in glioblastoma therapy","author":"Zheng","year":"2025","journal-title":"Mater. Today Bio."},{"issue":"6","key":"10.1016\/j.yexmp.2025.105004_bb0595","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1007\/s13577-023-00973-9","article-title":"The induction of ferroptosis by KLF11\/NCOA4 axis: the inhibitory role in clear cell renal cell carcinoma","volume":"36","author":"Zhou","year":"2023","journal-title":"Hum. Cell"},{"key":"10.1016\/j.yexmp.2025.105004_bb0600","first-page":"10","article-title":"A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis","author":"Zou","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:34:56Z","timestamp":1782952496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480025000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":120,"alternative-id":["S0014480025000541"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.105004","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism and importance of ferroptosis in clear cell renal cell carcinoma treatment","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.105004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105004"}}